Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI

Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Aug 23, 2024

Keywords

ClinConnect Summary

This clinical trial is examining a new way to diagnose and treat heart attacks, specifically looking at two types: occlusion myocardial infarction (OMI) and non-occlusion myocardial infarction (NOMI). The researchers believe that this new approach will help doctors better identify blockages in the heart's arteries, reduce the damage to the heart during a heart attack, maintain heart function, and lower the risk of serious long-term health problems, like repeated hospital visits or death.

To participate in the trial, individuals need to be over 18 years old and have a diagnosis of acute myocardial infarction, which is a type of heart attack. Unfortunately, people who are pregnant, those who have received certain treatments for heart attacks, or those who can't provide necessary medical information are not eligible. If you join the study, you can expect careful monitoring and evaluation to see how this new method compares to the standard ways of diagnosing and treating heart attacks.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • Age \>18 years
• • ECG and/or clinical diagnosis of acute myocardial infarction
• • Exclusion criteria
• • Active pregnancy or a suspicion of pregnancy
• • Rejection or withdrawal of consent
• • Failure to acquire any of the pre-participation ECGs
• • Non-ischemic myocardial injury
• • Application of thrombolytic therapy instead of primary PCI
• • Re-occlusion of the culprit lesion after intervention\*
• • New vessel occlusion during hospital stay\*
• • Exclusion from final analyses.